Hypoxic Mesenchymal Stem Cell Exosome‐Derived SLC25A3 Ameliorates Bronchopulmonary Dysplasia by Modulating Macrophage Polarization and Oxidative Stress
Cell Biochemistry and Function · 2025
DOI: 10.1002/cbf.70152 ↗At a glance
Journal article in Cell Biochemistry and Function, 2025. Written by Yanfang Zhang and 6 co-authors. Institution: Pediatric Medical Center, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, China. Major MEDLINE topics: Oxidative Stress, Exosomes, Mesenchymal Stem Cells, Bronchopulmonary Dysplasia. 60 references. Funded by: Hunan Province Natural Science Foundation Project, Hunan Provincial Department of Education Outstanding Youth Project.
Abstract (original language)
Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in preterm infants, characterized by dysregulated macrophage polarization and oxidative stress. While mesenchymal stem cell‐derived exosomes (MSC‐Exos) have shown protective effects against BPD, the role of exosomes derived from hypoxia‐preconditioned MSCs (Hypo‐Exos) remains unclear. This study aimed to investigate whether Hypo‐Exos alleviate BPD by modulating alveolar macrophage (AM) polarization and oxidative stress via the mitochondrial transporter SLC25A3. We utilized in vitro models of LPS‐induced M1 polarization and H 2 O 2 ‐induced oxidative stress in AMs, as well as an in vivo rat model of BPD induced by intermittent hypoxia. Our data demonstrate that hypoxic preconditioning enhanced exosome secretion from MSCs. Furthermore, hypoxic preconditioning promoted the packaging of SLC25A3 into these exosomes. Hypo‐Exos significantly suppressed M1 polarization, reduced oxidative stress, and ameliorated lung injury and dysfunction in BPD rats. Silencing SLC25A3 in MSCs abolished these protective effects. Mechanistically, SLC25A3 interacted with PTEN, leading to inhibition of PTEN expression and activation of the PI3K/AKT signaling pathway. Overexpression of PTEN reversed the beneficial effects of SLC25A3 on macrophage polarization and oxidative stress. These findings reveal that Hypo‐Exos deliver SLC25A3 to AMs, thereby downregulating PTEN, activating PI3K/AKT signaling, promoting M2 polarization, attenuating oxidative damage, and ultimately mitigating BPD progression. This study provides important mechanistic insights and suggests potential therapeutic avenues for exosome‐based treatment of BPD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Pediatric Medical Center, The First Affiliated Hospital of Hunan Normal University (Hunan Provincial People's Hospital), Changsha, China.
- Department of Pediatrics, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China.
- Hunan Provincial Key Laboratory of Pediatric Respirology, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China.
ORCID profiles: Juanmei Wang
Funding
- Hunan Province Natural Science Foundation Project
- Hunan Provincial Department of Education Outstanding Youth Project
Cite
APA
Zhang, Y., Zhang, A., Yang, J., Huang, F., Zhao, M., Huang, L., & Wang, J. (2025). Hypoxic Mesenchymal Stem Cell Exosome‐Derived SLC25A3 Ameliorates Bronchopulmonary Dysplasia by Modulating Macrophage Polarization and Oxidative Stress. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.70152
Vancouver
Zhang Y, Zhang A, Yang J, Huang F, Zhao M, Huang L, et al. Hypoxic Mesenchymal Stem Cell Exosome‐Derived SLC25A3 Ameliorates Bronchopulmonary Dysplasia by Modulating Macrophage Polarization and Oxidative Stress. Cell Biochemistry and Function. 2025. doi:10.1002/cbf.70152
BibTeX
@article{Zhang2025,
author = {Zhang, Yanfang and Zhang, Aimin and Yang, Jiale and Huang, Furong and Zhao, Menghua and Huang, Li and Wang, Juanmei},
title = {Hypoxic Mesenchymal Stem Cell Exosome‐Derived SLC25A3 Ameliorates Bronchopulmonary Dysplasia by Modulating Macrophage Polarization and Oxidative Stress},
journal = {Cell Biochemistry and Function},
year = {2025},
doi = {10.1002/cbf.70152}
}
EUVIMED